Connection

Anthony Alberg to Case-Control Studies

This is a "connection" page, showing publications Anthony Alberg has written about Case-Control Studies.
Connection Strength

1.982
  1. Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship. Anticancer Res. 2019 Sep; 39(9):5083-5087.
    View in: PubMed
    Score: 0.127
  2. Family history of cutaneous and noncutaneous malignancies in relation to the risk of keratinocyte carcinoma coupled with another type of cancer: A case-control study. J Am Acad Dermatol. 2016 Nov; 75(5):1066-1068.e7.
    View in: PubMed
    Score: 0.104
  3. Socioeconomic Status in Relation to the Risk of Ovarian Cancer in African-American Women: A Population-Based Case-Control Study. Am J Epidemiol. 2016 08 15; 184(4):274-83.
    View in: PubMed
    Score: 0.103
  4. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Aug; 22(8):1374-82.
    View in: PubMed
    Score: 0.083
  5. Association of matrix metalloproteinase-1 polymorphisms with risk of COPD and lung cancer and survival in lung cancer. Anticancer Res. 2012 Sep; 32(9):3917-22.
    View in: PubMed
    Score: 0.078
  6. SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer. Anticancer Res. 2012 Sep; 32(9):3923-8.
    View in: PubMed
    Score: 0.078
  7. A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer. Cancer Epidemiol. 2012 Oct; 36(5):e288-93.
    View in: PubMed
    Score: 0.077
  8. A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. J Invest Dermatol. 2012 May; 132(5):1354-62.
    View in: PubMed
    Score: 0.075
  9. Cruciferous vegetable intake and lung cancer risk: a nested case-control study matched on cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2534-40.
    View in: PubMed
    Score: 0.068
  10. Cigarette smoking and malignant melanoma: a case-control study. J Am Acad Dermatol. 2011 Jan; 64(1):84-90.
    View in: PubMed
    Score: 0.066
  11. Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Ann Epidemiol. 2009 Aug; 19(8):546-52.
    View in: PubMed
    Score: 0.062
  12. Alcohol consumption and the risk of nasopharyngeal carcinoma: a systematic review. Nutr Cancer. 2009; 61(1):1-15.
    View in: PubMed
    Score: 0.061
  13. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev. 2004; 28(3):187-93.
    View in: PubMed
    Score: 0.043
  14. Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study. Cancer. 2022 03 15; 128(6):1252-1259.
    View in: PubMed
    Score: 0.037
  15. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin. Anticancer Res. 2001 Nov-Dec; 21(6A):4051-4.
    View in: PubMed
    Score: 0.037
  16. The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine. Cancer Epidemiol Biomarkers Prev. 2000 Jul; 9(7):761-4.
    View in: PubMed
    Score: 0.034
  17. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev. 2000 May; 9(5):517-21.
    View in: PubMed
    Score: 0.033
  18. Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES). Gynecol Oncol. 2020 07; 158(1):123-129.
    View in: PubMed
    Score: 0.033
  19. Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma. J Nutr. 2019 09 01; 149(9):1606-1616.
    View in: PubMed
    Score: 0.032
  20. Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study. Cancer. 2019 12 15; 125(24):4442-4451.
    View in: PubMed
    Score: 0.032
  21. Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study. Cancer Causes Control. 2018 Nov; 29(11):1081-1091.
    View in: PubMed
    Score: 0.030
  22. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol. 2018 04 01; 47(2):460-472.
    View in: PubMed
    Score: 0.029
  23. Recreational physical activity and survival in African-American women with ovarian cancer. Cancer Causes Control. 2018 01; 29(1):77-86.
    View in: PubMed
    Score: 0.028
  24. Tubal ligation and ovarian cancer risk in African American women. Cancer Causes Control. 2017 Oct; 28(10):1033-1041.
    View in: PubMed
    Score: 0.028
  25. Dietary Quality and Ovarian Cancer Risk in African-American Women. Am J Epidemiol. 2017 06 15; 185(12):1281-1289.
    View in: PubMed
    Score: 0.027
  26. Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES). Cancer Causes Control. 2017 Jul; 28(7):699-708.
    View in: PubMed
    Score: 0.027
  27. Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women. Cancer Causes Control. 2017 May; 28(5):405-414.
    View in: PubMed
    Score: 0.027
  28. Dietary inflammatory index and risk of epithelial ovarian cancer in African American women. Int J Cancer. 2017 Feb 01; 140(3):535-543.
    View in: PubMed
    Score: 0.026
  29. Dairy, calcium, vitamin D and ovarian cancer risk in African-American women. Br J Cancer. 2016 Oct 25; 115(9):1122-1130.
    View in: PubMed
    Score: 0.026
  30. Reproductive factors and ovarian cancer risk in African-American women. Ann Epidemiol. 2016 09; 26(9):654-62.
    View in: PubMed
    Score: 0.026
  31. Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES). Cancer Epidemiol Biomarkers Prev. 2016 10; 25(10):1411-1417.
    View in: PubMed
    Score: 0.025
  32. Obesity, weight gain, and ovarian cancer risk in African American women. Int J Cancer. 2016 08 01; 139(3):593-600.
    View in: PubMed
    Score: 0.025
  33. Recreational physical activity and ovarian cancer risk in African American women. Cancer Med. 2016 06; 5(6):1319-27.
    View in: PubMed
    Score: 0.025
  34. Analgesic medication use and risk of epithelial ovarian cancer in African American women. Br J Cancer. 2016 Mar 29; 114(7):819-25.
    View in: PubMed
    Score: 0.025
  35. Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women. Br J Nutr. 2016 Feb 28; 115(4):694-702.
    View in: PubMed
    Score: 0.025
  36. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 2015 Nov; 102(5):1142-57.
    View in: PubMed
    Score: 0.024
  37. A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES). BMC Cancer. 2014 Sep 22; 14:688.
    View in: PubMed
    Score: 0.023
  38. Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3375-83.
    View in: PubMed
    Score: 0.016
  39. Secondhand tobacco smoke exposure and chronic rhinosinusitis: a population-based case-control study. Am J Rhinol Allergy. 2009 Nov-Dec; 23(6):562-7.
    View in: PubMed
    Score: 0.016
  40. Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk. Int J Cancer. 2009 Aug 01; 125(3):674-9.
    View in: PubMed
    Score: 0.016
  41. Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):215-22.
    View in: PubMed
    Score: 0.015
  42. C-reactive protein concentrations and subsequent ovarian cancer risk. Obstet Gynecol. 2007 Apr; 109(4):933-41.
    View in: PubMed
    Score: 0.013
  43. Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcohol Clin Exp Res. 2007 Mar; 31(3):467-76.
    View in: PubMed
    Score: 0.013
  44. Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res. 2005 Oct 15; 65(20):9566-73.
    View in: PubMed
    Score: 0.012
  45. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):633-7.
    View in: PubMed
    Score: 0.012
  46. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis. 2004 Dec; 25(12):2467-72.
    View in: PubMed
    Score: 0.011
  47. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003 Aug 20; 95(16):1218-26.
    View in: PubMed
    Score: 0.010
  48. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev. 2003 May; 12(5):460-3.
    View in: PubMed
    Score: 0.010
  49. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 2003 Feb 15; 157(4):335-44.
    View in: PubMed
    Score: 0.010
  50. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis. 2003 Feb; 24(2):269-74.
    View in: PubMed
    Score: 0.010
  51. Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2002 May; 11(5):451-7.
    View in: PubMed
    Score: 0.010
  52. 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst. 2001 May 16; 93(10):768-76.
    View in: PubMed
    Score: 0.009
  53. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000 Dec 20; 92(24):2018-23.
    View in: PubMed
    Score: 0.009
  54. A prospective study of plasma ascorbic acid concentrations and breast cancer (United States). Cancer Causes Control. 2000 Mar; 11(3):279-83.
    View in: PubMed
    Score: 0.008
  55. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999 Jun; 8(6):525-32.
    View in: PubMed
    Score: 0.008
  56. Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1998 Oct; 7(10):945-9.
    View in: PubMed
    Score: 0.007
  57. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst. 1998 Apr 01; 90(7):512-8.
    View in: PubMed
    Score: 0.007
  58. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev. 1997 Nov; 6(11):907-16.
    View in: PubMed
    Score: 0.007
  59. Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst. 1996 Jan 03; 88(1):32-7.
    View in: PubMed
    Score: 0.006
  60. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA. 1995 Dec 27; 274(24):1926-30.
    View in: PubMed
    Score: 0.006
  61. Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta- carotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiol Biomarkers Prev. 1995 Dec; 4(8):837-42.
    View in: PubMed
    Score: 0.006
  62. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994; 18(2):79-85.
    View in: PubMed
    Score: 0.005
  63. Prospective study of serum CA-125 levels as markers of ovarian cancer. JAMA. 1993 Mar 03; 269(9):1123-6.
    View in: PubMed
    Score: 0.005
  64. Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb; 2(1):33-5.
    View in: PubMed
    Score: 0.005
  65. Pulmonary embolism in the cardiac surgical patient. Ann Thorac Surg. 1992 Jun; 53(6):988-91.
    View in: PubMed
    Score: 0.005
  66. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res. 1992 Jan 01; 52(1):1-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.